KCG
NKTR icon

Knight Capital Group’s Nektar Therapeutics NKTR Stock Holding History

Knight Capital Group’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$121K Buy
+700
New +$107K ﹤0.01% 2896

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Knight Capital Group's NKTR Position: Q2 2013 in Review

Knight Capital Group opened a new position in Nektar Therapeutics (NKTR) in Q2 2013: 700 shares worth $121K. The stake represents ﹤0.01% of the portfolio and ranks #2896 among its holdings.

139 funds tracked by Wall St. Rank hold NKTR as of Q2 2013.

  • Knight Capital Group held 700 shares of Nektar Therapeutics worth $121K as of Q2 2013.
  • Nektar Therapeutics was a new Knight Capital Group position in Q2 2013.
  • Nektar Therapeutics made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #2896 holding.
  • 139 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.